AdvaMed Names Former Exec as President

Industry association AdvaMed (Washington, DC) has selected Stephen J. Ubl as its new president and CEO. Current AdvaMed chairman Art Collins, chairman and CEO of Medtronic Inc. (Minneapolis), made the announcement of Ubl's appointment in the middle of July. Ubl succeeds Pamela Bailey, who left the organization in March of this year to head the Cosmetic, Toiletry, and Fragrance Association (CTFA; Washington, DC).

Ubl formerly served as AdvaMed's executive vice president for government relations from 1998 until last year, when he left to form his own healthcare consulting firm, Ubl Health Solutions LLC (Washington, DC). That firm became defunct upon Ubl's acceptance of his new position.

In making the announcement, Collins cited Ubl's “rare combination of policy depth and political acumen that has earned bipartisan respect on Capitol Hill and among policymakers. Steve's knowledge of the medical technology industry, along with his demonstrated leadership and successes on the legislative and regulatory fronts, makes him the ideal person to lead AdvaMed into the future.”

Collins led a three-person search committee that included past AdvaMed chairman Dennis N. Longstreet, company group chairman of Johnson & Johnson Inc. (New Brunswick, NJ), and chairman-elect Edward J. Ludwig, chairman and CEO of Becton Dickinson and Co. (Franklin Lakes, NJ).